Tumors associated with p53 germline mutations: a synopsis of 91 families.
about
Li-fraumeni syndromeConstitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancersTransforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitariesEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerDNA methylation, its mediators and genome integrityMBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological rolesPrepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary glandIARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation toolsImpact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.Review paper: origin and molecular pathology of adrenocortical neoplasmsPathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.The p53 inhibitor MDM2 facilitates Sonic Hedgehog-mediated tumorigenesis and influences cerebellar foliationSoft tissue sarcomas and p53 mutationsGermline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer riskMap making in the 21st century: charting breast cancer susceptibility pathways in rodent models.Zebrafish models of p53 functions.Development and translational imaging of a TP53 porcine tumorigenesis modelMbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.The cellular origin for malignant glioma and prospects for clinical advancements.Breast cancer in young women: special considerations in multidisciplinary care.Biology of childhood acute lymphoblastic leukemia.ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiencyDistinct requirements for Ras oncogenesis in human versus mouse cells.Prevalence of germline TP53 mutations in HER2+ breast cancer patients.Choroid plexus tumours.Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival.Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas.Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.Chromosomal imbalances in choroid plexus tumors.Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasRepression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.p53 mutations in urinary bladder cancer.Gastric cancer in individuals with Li-Fraumeni syndromeEstrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice
P2860
Q22241780-E2D28C31-1E51-4CCB-B9D8-B5458F55CE2FQ24534231-66C8D7E4-922C-4822-AC33-C5D6459FB71AQ24678553-FF33C327-C41A-4E9F-B388-158D2CF92419Q27010209-4E3DFAE0-314E-48B6-A2CB-71430CDD87DBQ28080760-BF93C27E-D2FF-489A-AF34-7993EE0F3B9CQ28280293-E33FF28D-3549-4887-AACA-135DC579DEF2Q28573752-F60D3B81-F161-4201-B036-10A09C5EF2B2Q30429006-7DB0A496-7EC7-4B76-A1EA-1AF34866DC24Q30554353-8275B20F-C3B3-46DE-A6B5-9B3D574E8F7DQ33593066-5EECCD11-311D-427E-AFE6-AD14B811D6B8Q33612954-D8D51FF2-3980-47F3-B720-C60CBBDA876DQ33703779-0636CBE0-6F06-4164-8CA3-644DDA437073Q33855554-9F016927-E0B5-4C65-9E1E-AC94C886999CQ33898768-3B19E698-0AE9-47E8-99E9-26DE133E8DC0Q33905119-4B99919D-404C-47F1-A64C-4918B22B55AFQ33908246-C0D3CD32-978A-4FB0-90EF-4EB7959A6866Q34014685-C9F4CFA0-F601-4AB0-BE06-771479F92FE3Q34117482-E988BBE2-4455-4A2D-851E-2103D08F2940Q34157868-426D3D8A-E016-4175-B8C1-0743DF1635ABQ34276557-DE5821FE-26D6-464C-8FBB-83B2A79D34ACQ34306522-DE115B76-DE51-4937-B864-894D1455215BQ34605953-4629DA3B-5F1A-4384-AA44-68662F149AE0Q34619732-3B38A307-8B0D-47F4-AF11-20D315FE18E2Q34787097-00A90579-B7DC-46AB-A66A-61538FB82CF9Q34789542-B1FD2ABC-7A56-4014-BFAB-61D03642D5BEQ34981284-44CC331D-0A5B-4190-BFE9-72B06D57CB91Q35177312-24058727-B17D-4A58-AD79-CCA9931ECBA2Q35617133-F440188C-77A6-41C5-B92F-90B6447EA320Q35745674-11D2C241-D769-4028-9F26-F7D1F354C8F8Q35748808-F4121719-DF9F-42DD-A3D8-CFB58A718E68Q35770577-54DBDAEF-60D0-4414-8DE2-C196A53CBB10Q35788860-3C5CAD21-DF8C-40F7-AFAA-BA5263A0F86DQ35829654-CB55D74C-67E0-418C-8041-7BE23FDA1808Q36048192-F01FBCCC-C29B-4A31-8F38-35602735E52AQ36113210-08034925-EB7A-4E56-944A-F8D78501D9C2Q36169808-E2A89B29-A014-4EFD-A0BA-78923091943EQ36245632-87614E94-6B67-4134-B6B4-6CB0EACE5AE7Q36622335-6D7D9CDF-9158-4F22-AEE7-C099D5EE1BF8Q36678769-7A9161AB-A45D-4AA6-A9C9-03D63269D600Q36787334-1059E280-BC1A-48C6-BB0F-B70A10BAECC9
P2860
Tumors associated with p53 germline mutations: a synopsis of 91 families.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@ast
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@en
type
label
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@ast
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@en
prefLabel
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@ast
Tumors associated with p53 germline mutations: a synopsis of 91 families.
@en
P2093
P2860
P1476
Tumors associated with p53 germline mutations: a synopsis of 91 families
@en
P2093
P2860
P407
P577
1997-01-01T00:00:00Z